{"id":"https://openalex.org/W2970995457","doi":"https://doi.org/10.1111/dom.13856","title":"Superior efficacy with a fixed\u2010ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin\u2010na\u00efve Japanese patients with type 2 diabetes in a phase 3, open\u2010label, randomized trial","display_name":"Superior efficacy with a fixed\u2010ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin\u2010na\u00efve Japanese patients with type 2 diabetes in a phase 3, open\u2010label, randomized trial","publication_year":2019,"publication_date":"2019-08-13","ids":{"openalex":"https://openalex.org/W2970995457","doi":"https://doi.org/10.1111/dom.13856","mag":"2970995457","pmid":"https://pubmed.ncbi.nlm.nih.gov/31407845","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6899795"},"language":"en","primary_location":{"id":"doi:10.1111/dom.13856","doi":"https://doi.org/10.1111/dom.13856","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13856","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13856","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13856","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036190568","display_name":"Kohei Kaku","orcid":"https://orcid.org/0000-0003-1574-0565","observed_orcids":["https://orcid.org/0000-0003-1574-0565"]},"institutions":[{"id":"https://openalex.org/I189996419","display_name":"Kawasaki Medical School","ror":"https://ror.org/059z11218","country_code":"JP","type":"education","lineage":["https://openalex.org/I189996419"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kohei Kaku","raw_affiliation_strings":["Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Japan"],"raw_orcid":"https://orcid.org/0000-0003-1574-0565","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Japan","institution_ids":["https://openalex.org/I189996419"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067248419","display_name":"Eiichi Araki","orcid":"https://orcid.org/0000-0002-4064-7525","observed_orcids":["https://orcid.org/0000-0002-4064-7525"]},"institutions":[{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Eiichi Araki","raw_affiliation_strings":["Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan","institution_ids":["https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014105657","display_name":"Yukio Tanizawa","orcid":"https://orcid.org/0000-0002-4742-8245","observed_orcids":["https://orcid.org/0000-0002-4742-8245"]},"institutions":[{"id":"https://openalex.org/I173915773","display_name":"Yamaguchi University","ror":"https://ror.org/03cxys317","country_code":"JP","type":"education","lineage":["https://openalex.org/I173915773"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yukio Tanizawa","raw_affiliation_strings":["Graduate School of Medicine, Yamaguchi University, Ube, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Medicine, Yamaguchi University, Ube, Japan","institution_ids":["https://openalex.org/I173915773"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028110734","display_name":"Bue F. Ross Agner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Bue Ross Agner","raw_affiliation_strings":["Novo Nordisk A/S  S\u00f8borg Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S  S\u00f8borg Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060585389","display_name":"Tomoyuki Nishida","orcid":"https://orcid.org/0009-0004-5812-7167","observed_orcids":["https://orcid.org/0009-0004-5812-7167"]},"institutions":[{"id":"https://openalex.org/I4405265707","display_name":"Novo Nordisk Pharma Ltd. (Japan)","ror":"https://ror.org/05gzvb546","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405265707"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoyuki Nishida","raw_affiliation_strings":["Novo Nordisk Pharma Ltd, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Pharma Ltd, Tokyo, Japan","institution_ids":["https://openalex.org/I4405265707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039428474","display_name":"Mattis Flyvholm Ranthe","orcid":"https://orcid.org/0000-0002-6363-6386","observed_orcids":["https://orcid.org/0000-0002-6363-6386"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Mattis Ranthe","raw_affiliation_strings":["Novo Nordisk A/S  S\u00f8borg Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S  S\u00f8borg Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077189198","display_name":"Nobuya Inagaki","orcid":"https://orcid.org/0000-0001-8261-2593","observed_orcids":["https://orcid.org/0000-0001-8261-2593"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobuya Inagaki","raw_affiliation_strings":["Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I22299242"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5036190568"],"corresponding_institution_ids":["https://openalex.org/I189996419"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":1.4494,"has_fulltext":true,"cited_by_count":28,"citation_normalized_percentile":{"value":0.86915224,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"21","issue":"12","first_page":"2674","last_page":"2683"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-degludec","display_name":"insulin degludec","score":0.8740000128746033},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ideglira","display_name":"IDegLira","score":0.7620000243186951},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8669999837875366},{"id":"https://openalex.org/keywords/fixed-ratio-combination-therapy","display_name":"fixed-ratio combination therapy","score":0.7699999809265137},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9200000166893005},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.5120000243186951},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.984000027179718},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.6449999809265137},{"id":"https://openalex.org/keywords/insulin-naive-patients","display_name":"insulin-naive patients","score":0.5740000009536743},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.7450000047683716},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.7059999704360962},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9806325435638428},{"id":"https://openalex.org/C2775927303","wikidata":"https://www.wikidata.org/wiki/Q16252338","display_name":"Insulin degludec","level":5,"score":0.9599659442901611},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8549326658248901},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6780436635017395},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5560596585273743},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.48302754759788513},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.48107481002807617},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4591578245162964},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3310545086860657},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2897163927555084},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.1019422709941864}],"mesh":[{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/dom.13856","doi":"https://doi.org/10.1111/dom.13856","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13856","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13856","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5872031","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6899795","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6899795","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6899795","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmid:31407845","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31407845","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1111/dom.13856","doi":"https://doi.org/10.1111/dom.13856","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13856","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13856","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G3443786474","display_name":"Elucidation of the effects of anti-diabetes and anti-complications by activation of heat shock response pathway and translation for clinical application","funder_award_id":"17H04201","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G7107328924","display_name":"Organ- and intermolecular interactions of heat stress response pathway activation that exert anti-diabetic effects","funder_award_id":"18K08482","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320316238","display_name":"Kowa Company","ror":"https://ror.org/009z2z347"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320327566","display_name":"Mitsubishi Tanabe Pharma Corporation","ror":"https://ror.org/038ehsm73"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2970995457.pdf","grobid_xml":"https://content.openalex.org/works/W2970995457.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1556145647","https://openalex.org/W1606810773","https://openalex.org/W1826263849","https://openalex.org/W1977102586","https://openalex.org/W1997529585","https://openalex.org/W2029145065","https://openalex.org/W2030875300","https://openalex.org/W2033665483","https://openalex.org/W2043092889","https://openalex.org/W2053939314","https://openalex.org/W2056526409","https://openalex.org/W2067533175","https://openalex.org/W2092619571","https://openalex.org/W2106709036","https://openalex.org/W2126674572","https://openalex.org/W2126862523","https://openalex.org/W2135064706","https://openalex.org/W2135298024","https://openalex.org/W2146681672","https://openalex.org/W2152203840","https://openalex.org/W2341906203","https://openalex.org/W2516820342","https://openalex.org/W2559748650","https://openalex.org/W2582426955","https://openalex.org/W2606399391","https://openalex.org/W2715646815","https://openalex.org/W2750021396","https://openalex.org/W2765159569","https://openalex.org/W2792254305","https://openalex.org/W2794676804","https://openalex.org/W2894993577","https://openalex.org/W2911886982","https://openalex.org/W4211190017","https://openalex.org/W4212810717"],"related_works":["https://openalex.org/W2067533175","https://openalex.org/W2969317099","https://openalex.org/W2126862523","https://openalex.org/W3130078423","https://openalex.org/W4283662418","https://openalex.org/W3192721569","https://openalex.org/W2922454596","https://openalex.org/W2775066811","https://openalex.org/W2283009301","https://openalex.org/W2903572805"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"investigate":[2],"the":[3],"efficacy":[4],"and":[5,79,107,121,134,156,162,251,256,268,275,285],"safety":[6],"of":[7,130,136,167,180,186,253,272,281,287],"insulin":[8,225],"degludec/liraglutide":[9],"(IDegLira)":[10],"compared":[11],"with":[12,19,100,105,159,229,292],"its":[13],"individual":[14,85],"components":[15],"in":[16,178,270,279,289],"Japanese":[17,290],"people":[18,291],"type":[20],"2":[21],"diabetes":[22],"(T2D)":[23],"uncontrolled":[24],"on":[25,84],"an":[26],"oral":[27],"antidiabetic":[28],"drug":[29],"(OAD).":[30],"MATERIALS":[31],"AND":[32],"METHODS:":[33],"This":[34],"52-week,":[35],"open-label,":[36],"multicentre,":[37],"treat-to-target":[38],"trial":[39],"randomized":[40],"participants":[41,258],"(n":[42],"=":[43,172],"819)":[44],"1:1:1":[45],"to":[46,55,132,138,266,277],"IDegLira,":[47,160],"liraglutide":[48,139,181,211,269],"1.8":[49],"mg":[50,70],"or":[51,188],"degludec,":[52,78],"as":[53],"add-on":[54],"their":[56],"pre-trial":[57],"OAD.":[58],"The":[59],"maximum":[60,75],"IDegLira":[61,101,131,137,168,193,230,263],"dose":[62,65,76,226],"was":[63,73,227,264],"50":[64],"steps":[66],"(50":[67],"U":[68],"degludec/1.8":[69],"liraglutide),":[71],"there":[72],"no":[74],"for":[77,143,192],"both":[80,144],"were":[81,112,151,194,245],"titrated":[82],"based":[83],"blood":[86,189],"glucose":[87],"measurements.":[88],"RESULTS:":[89],"After":[90],"52":[91],"weeks,":[92],"glycated":[93],"haemoglobin":[94],"(HbA1c)":[95],"decreased":[96],"by":[97],"26":[98],"mmol/mol":[99,104,114,123],"vs":[102],"20":[103],"degludec":[106,133,161,170,197,234,267,278],"liraglutide:":[108],"estimated":[109],"treatment":[110],"differences":[111],"-6.91":[113],"(95%":[115,124],"confidence":[116],"interval":[117],"[CI]":[118],"-8.18;":[119],"-5.64)":[120],"-5.30":[122],"CI":[125,202,216],"-6.58;":[126],"-4.03),":[127],"confirming":[128],"non-inferiority":[129],"superiority":[135,166],"(P":[140,171,182],"<":[141,183,206,220,238],".0001":[142],"[primary":[145],"endpoint]).":[146],"Mean":[147,222],"body":[148,282],"weight":[149,283],"changes":[150],"2.9":[152],"kg,":[153],"4.1":[154],"kg":[155,158],"-1.0":[157],"liraglutide,":[163],"respectively,":[164],"showing":[165],"versus":[169,196,210,233],".0001),":[173,207],"but":[174,208],"a":[175],"significant":[176],"difference":[177],"favour":[179],".0001).":[184,221,239],"Rates":[185],"severe":[187],"glucose-confirmed":[190],"hypoglycaemia":[191,288],"lower":[195,228],"(rate":[198,212],"ratio":[199,213],"0.48":[200],"[95%":[201,215],"0.35;":[203],"0.68];":[204],"P":[205,219,237],"higher":[209],"37.58":[214],"19.80;":[217],"71.31];":[218],"daily":[223],"total":[224],"(27.7":[231],"U)":[232],"(34.8":[235],"U;":[236],"Overall":[240],"adverse":[241],"event":[242],"(AE)":[243],"rates":[244,286],"similar.":[246],"In":[247],"total,":[248],"34.9%,":[249],"22.9%":[250],"41.8%":[252],"IDegLira-,":[254],"degludec-":[255],"liraglutide-treated":[257],"experienced":[259],"gastrointestinal":[260],"AEs.":[261],"CONCLUSION:":[262],"superior":[265,276],"terms":[271,280],"HbA1c":[273],"reduction":[274],"change":[284],"T2D.":[293]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2019-09-05T00:00:00"}